Abstract:Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by the accumulation of amyloid plaques in the brain. The toxicity of amyloid to neuronal cell surfaces arises from interactions between small intermediate aggregates, namely amyloid oligomers, and the cell membrane. The nature of these interactions changes with age and disease progression. In our previous work, we demonstrated that both membrane composition and nanoscale structure play crucial roles in amyloid-membrane interactions. In our previous work, we demonstrated that both membrane composition and nanoscale structure play crucial roles in amyloid toxicity, and that membrane models mimicking healthy neuron were less affected by amyloid than model membranes mimicking AD neuronal membranes. This understanding introduces the possibility of modifying membrane properties with membrane-active molecules, such as melatonin, to protect them from amyloid-induced damage. In the present study, we employed atomic force microscopy (AFM) and localized surface plasmon resonance (LSPR) to investigate the protective effects of melatonin. We utilized synthetic lipid membranes that mimic the neuronal cellular membrane at various stages of AD and explored their interactions with amyloid-β (1-42) in the presence of melatonin. Our findings reveal that the early diseased membrane model is particularly vulnerable to amyloid binding and subsequent damage. However, melatonin exerts its most potent protective effect on this early-stage membrane. These results suggest that melatonin could act at the membrane level to alleviate amyloid toxicity, offering the most protection during the initial stages of AD.

P4-331: Melatonin Partially Reverses Calyculin A-Induced Axonal Transport Defects in N2A Cells

AbstractPoster presentation: Wednesday posterP4-331: Melatonin partially reverses calyculin a-induced axonal transport defects in N2A cells

Melatonin Reduces the Impairment of Axonal Transport and Axonopathy Induced by Calyculin A.

Melatonin Ameliorates Alzheimer-like Pathological Changes and Spatial Memory Retention Impairment Induced by Calyculin A

P2–017: Inhibition of Protein Phosphatases Induces Impairment in Axonal Transport and Spatial Memory Retention

Stimulation of autophagy prevents amyloid-β peptide-induced neuritic degeneration in PC12 cells.

Inhibition of Melatonin Biosynthesis Induces Neurofilament Hyperphosphorylation with Activation of Cyclin-Dependent Kinase 5

Melatonin-mediated calcineurin inactivation attenuates amyloid beta-induced apoptosis

Localized surface plasmon resonance and atomic force microscopy study of model lipid membranes and their interactions with amyloid and melatonin

Constant illumination induces Alzheimer-like damages with endoplasmic reticulum involvement and the protection of melatonin

Melatonin decreases levels of S100β and NFκ B, increases levels of synaptophysinina rat model of Alzheimer's disease

Melatonin Ameliorates Cognitive Deficits Through Improving Mitophagy in a Mouse Model of Alzheimer's Disease

Melatonin regulates A production/clearance balance and A neurotoxicity: A potential therapeutic molecule for Alzheimer's disease

Increased expression of cdk5/p25 in N2a cells leads to hyperphosphorylation and impaired axonal transport of neurofilament proteins.

Protective effects of melatonin on mitochondrial biogenesis and mitochondrial structure and function in the HEK293-APPswe cell model of Alzheimer's disease.

Partial Amelioration of Synaptic and Cognitive Deficits by Inhibiting Cofilin Dephosphorylation in an Animal Model of Alzheimer's Disease.

Enhancing the retrograde axonal transport by curcumin promotes autophagic flux in N2a/APP695swe cells

Melatonin Supplementation Alleviates Impaired Spatial Memory by Influencing Aβ1-42 Metabolism via γ-Secretase in the icvAβ1-42 Rat Model with Pinealectomy

Melatonin Protects Against Aβ‐induced Neurotoxicity in Primary Neurons Via Mir‐132/pten/akt/foxo3a Pathway

Acute Impairment of Mitochondrial Trafficking by Beta-Amyloid Peptides in Hippocampal Neurons

Melatonin protects against amyloid-β-induced impairments of hippocampal LTP and spatial learning in rats